Patient advocates and some experts are expressing growing alarm over the perceived risks of a rare disease drug sold by ...
Zacks Investment Research on MSN
Veeva Systems' Basics gains traction with 175+ emerging biotech firms
Veeva Systems VEEV recently announced that more than 175 emerging biotechnology companies are using Veeva Basics to establish ...
The initiative will develop digital standards for technology transfer, knowledge sharing and AI-enabled tools across the drug development lifecycle.
Clever Culture Systems will expand its reach across the North American and Singapore pharmaceutical manufacturing markets ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
The Journal of Pharmaceutical Investigation has announced a January 2027 special issue on translational advances in ...
VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today presented first in vivo proof-of-concept data and additional in vitro data validating its ...
Raleigh-Durham, North Carolina; King of Prussia, Pennsylvania, USA; Bern, Switzerland, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kymanox®, a leading ...
Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...
Earlier this month, Quantum BioPharma announced a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research ...
Researchers developed a ‘virtual biotech’ made up of as many as 37,000 agents reporting to an 'chief scientist'.
While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results